title: Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia.
authors.forename: Kalisvar
authors.initials: K
authors.lastname: Marimuthu
authors.forename: Tat Ming
authors.initials: TM
authors.lastname: Ng
authors.forename: Christine
authors.initials: C
authors.lastname: Teng
authors.forename: Tse Peng
authors.initials: TP
authors.lastname: Lim
authors.forename: Tse Hsien
authors.initials: TH
authors.lastname: Koh
authors.forename: Thean Yen
authors.initials: TY
authors.lastname: Tan
authors.forename: Prabha Unny
authors.initials: PU
authors.lastname: Krishnan
authors.forename: David
authors.initials: D
authors.lastname: Lye
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D016022:Case-Control Studies; D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects / Q000201:enzymology; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000382:microbiology; D000077727:Ertapenem; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology; D005260:Female; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D012307:Risk Factors; D013845:Thienamycins / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome; D047090:beta-Lactams / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D047090:beta-Lactams; D000077731:Meropenem; D000077727:Ertapenem